Clinical Trials Directory

Trials / Unknown

UnknownNCT00622934

Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients

Relationship Between Clinical Recovery and Oxidative Stress and Inflammation Following Usage of Erythropoietin in Admitted Traumatic Patient In Intensive Care Unit

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Erythropoietin decrease stress responses and inflammation in trauma patient.

Detailed description

Transfusion of blood products has many disadvantages. Erythropoietin is used to increase red blood cells production and decrease such disadvantages.In some studies anti inflammatory effects is shown for Erythropoietin. One of the most problems in the intensive care unit is stress response. we are going to evaluate effects of erythropoietin on oxidative stress and inflammation in trauma patient in intensive care unit.

Conditions

Interventions

TypeNameDescription
DRUGerythropoietin300mg/kg erythropoietin 3 times on the first week of admission
DRUGplaceboplacebo

Timeline

Start date
2007-07-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2008-02-25
Last updated
2010-11-18

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00622934. Inclusion in this directory is not an endorsement.